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We used Ig-Seq, a liquid chromatography tandem mass spectrometry (LC-MS/MS)–based serum antibody 
proteomics methodology, to determine the clonal composition and dynamics of the H1N1 California/7/2009 
(CA09) hemagglutinin (HA)-reactive antibody repertoire over 5 years in a well-characterized donor from whom a 
large number of homosubtypic and heterosubtypic neutralizing monoclonal antibodies had been previously 
isolated by B cell analysis. The donor was infected with the CA09 strain in 2009 and immunized annually for the 
next five years with seasonal influenza vaccine which contained the CA09 strain. We find that the serological 
repertoire in this donor was highly static, with a modest number (24) of persistent antibody clonotypes, detected 
in serum for at least 4 out of 5 years, accounting on average for 72.6 ± 10.0% of the repertoire to the CA09 HA. 
These persistent antibodies: (i) displayed a higher degree of somatic hypermutation relative to antibodies that 
could be detected in the serum transiently (i.e. lasted less than 1 year in serum); (ii) comprised a significant 
fraction that also bound to HA from a phylogenetically distant H5N1 A/Vietnam/1203/2004 (VT04) strain, a 
hallmark of stem-binding antibodies due to the lack of homology between CA09 and VT04 in the head region of 
HA and (iii) perhaps most strikingly, but consistent with the wealth of heterosubtypic neutralizing antibodies that 
had previously been identified from this donor, some of the most abundant persistent antibody clonotypes, 
including the dominant clone that accounted on average for 18.6 ± 12.3% of the serum titer across 5 years, 
neutralized both the CA09 and VT04 influenza strains. Our analysis highlights the magnitude of ‘serological 
imprinting’ in the donor’s serum response to CA09, indicates that seasonal vaccination can further reinforce a 
stable serological memory and finally suggests that once elicited, antibodies cross-reactive between CA09 and 
VT04 with heterosubtypic neutralization activity, thus likely to bind to HA-stem, can persist for many years, 
which is a fundamental goal of universal influenza vaccines. 
 
